APO Research

APO RESEARCH · REPORT

Patient Scheduling Platform

Selected research

Market Analysis & Forecast

Global Patient Scheduling Platform Market Analysis and Forecast 2026-2032

Market perspective

The global Patient Scheduling Platform market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Patient Scheduling Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Patient Scheduling Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Patient Scheduling Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Patient Scheduling Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Patient Scheduling Platform include WellSky Scheduling, AdvancedMD, Weave, Carepatron, DoctorConnect.net, McKesson, WebPT, Yocale and Luma Health, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Patient Scheduling Platform, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Patient Scheduling Platform, also provides the revenue of main regions and countries. Of the upcoming market potential for Patient Scheduling Platform, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Patient Scheduling Platform revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Patient Scheduling Platform market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Patient Scheduling Platform revenue, projected growth trends, production technology, application and end-user industry.

Patient Scheduling Platform Segment by Company

WellSky Scheduling

AdvancedMD

Weave

Carepatron

DoctorConnect.net

McKesson

WebPT

Yocale

Luma Health

Setmore

oicent Communications

Total Recall Solutions

Mediware Information Systems

TimeTrade Systems

Relatient

Skedulo

American Medical Software

Clearwave

Upvio

TIMIFY

Nuesoft Technologies

Patient Scheduling Platform Segment by Type

Cloud-based

On-premise

Patient Scheduling Platform Segment by Application

Hospital

Specialist Clinic

Others

Patient Scheduling Platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Patient Scheduling Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Patient Scheduling Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Patient Scheduling Platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Patient Scheduling Platform in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Patient Scheduling Platform company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Patient Scheduling Platform revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Patient Scheduling Platform Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Cloud-based Major Player Table 3. On-premise Major Player Table 4. Global Patient Scheduling Platform Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Player Table 6. Specialist Clinic Major Player Table 7. Others Major Player Table 8. Patient Scheduling Platform Industry Trends Table 9. Patient Scheduling Platform Industry Drivers Table 10. Patient Scheduling Platform Industry Opportunities and Challenges Table 11. Patient Scheduling Platform Industry Restraints Table 12. Global Patient Scheduling Platform Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Patient Scheduling Platform Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Patient Scheduling Platform Market Share by Region (2021-2026) Table 15. Global Patient Scheduling Platform Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Patient Scheduling Platform Market Share by Region (2027-2032) Table 17. Global Patient Scheduling Platform Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Patient Scheduling Platform Revenue Market Share by Players (2021-2026) Table 19. Global Patient Scheduling Platform Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Patient Scheduling Platform Key Players Headquarters & Area Served Table 21. Global Patient Scheduling Platform Players, Product Type & Application Table 22. Global Patient Scheduling Platform Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Patient Scheduling Platform by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Patient Scheduling Platform Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Patient Scheduling Platform Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Patient Scheduling Platform Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Patient Scheduling Platform Revenue Market Share by Type (2021-2026) Table 29. Global Patient Scheduling Platform Revenue Market Share by Type (2027-2032) Table 30. Global Patient Scheduling Platform Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Patient Scheduling Platform Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Patient Scheduling Platform Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Patient Scheduling Platform Revenue Market Share by Application (2021-2026) Table 34. Global Patient Scheduling Platform Revenue Market Share by Application (2027-2032) Table 35. WellSky Scheduling Company Information Table 36. WellSky Scheduling Business Overview Table 37. WellSky Scheduling Patient Scheduling Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. WellSky Scheduling Patient Scheduling Platform Product Portfolio Table 39. WellSky Scheduling Recent Development Table 40. AdvancedMD Company Information Table 41. AdvancedMD Business Overview Table 42. AdvancedMD Patient Scheduling Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. AdvancedMD Patient Scheduling Platform Product Portfolio Table 44. AdvancedMD Recent Development Table 45. Weave Company Information Table 46. Weave Business Overview Table 47. Weave Patient Scheduling Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Weave Patient Scheduling Platform Product Portfolio Table 49. Weave Recent Development Table 50. Carepatron Company Information Table 51. Carepatron Business Overview Table 52. Carepatron Patient Scheduling Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Carepatron Patient Scheduling Platform Product Portfolio Table 54. Carepatron Recent Development Table 55. DoctorConnect.net Company Information Table 56. DoctorConnect.net Business Overview Table 57. DoctorConnect.net Patient Scheduling Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. DoctorConnect.net Patient Scheduling Platform Product Portfolio Table 59. DoctorConnect.net Recent Development Table 60. McKesson Company Information Table 61. McKesson Business Overview Table 62. McKesson Patient Scheduling Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. McKesson Patient Scheduling Platform Product Portfolio Table 64. McKesson Recent Development Table 65. WebPT Company Information Table 66. WebPT Business Overview Table 67. WebPT Patient Scheduling Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. WebPT Patient Scheduling Platform Product Portfolio Table 69. WebPT Recent Development Table 70. Yocale Company Information Table 71. Yocale Business Overview Table 72. Yocale Patient Scheduling Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Yocale Patient Scheduling Platform Product Portfolio Table 74. Yocale Recent Development Table 75. Luma Health Company Information Table 76. Luma Health Business Overview Table 77. Luma Health Patient Scheduling Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Luma Health Patient Scheduling Platform Product Portfolio Table 79. Luma Health Recent Development Table 80. Setmore Company Information Table 81. Setmore Business Overview Table 82. Setmore Patient Scheduling Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Setmore Patient Scheduling Platform Product Portfolio Table 84. Setmore Recent Development Table 85. oicent Communications Company Information Table 86. oicent Communications Business Overview Table 87. oicent Communications Patient Scheduling Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. oicent Communications Patient Scheduling Platform Product Portfolio Table 89. oicent Communications Recent Development Table 90. Total Recall Solutions Company Information Table 91. Total Recall Solutions Business Overview Table 92. Total Recall Solutions Patient Scheduling Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Total Recall Solutions Patient Scheduling Platform Product Portfolio Table 94. Total Recall Solutions Recent Development Table 95. Mediware Information Systems Company Information Table 96. Mediware Information Systems Business Overview Table 97. Mediware Information Systems Patient Scheduling Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Mediware Information Systems Patient Scheduling Platform Product Portfolio Table 99. Mediware Information Systems Recent Development Table 100. TimeTrade Systems Company Information Table 101. TimeTrade Systems Business Overview Table 102. TimeTrade Systems Patient Scheduling Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. TimeTrade Systems Patient Scheduling Platform Product Portfolio Table 104. TimeTrade Systems Recent Development Table 105. Relatient Company Information Table 106. Relatient Business Overview Table 107. Relatient Patient Scheduling Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Relatient Patient Scheduling Platform Product Portfolio Table 109. Relatient Recent Development Table 110. Skedulo Company Information Table 111. Skedulo Business Overview Table 112. Skedulo Patient Scheduling Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Skedulo Patient Scheduling Platform Product Portfolio Table 114. Skedulo Recent Development Table 115. American Medical Software Company Information Table 116. American Medical Software Business Overview Table 117. American Medical Software Patient Scheduling Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. American Medical Software Patient Scheduling Platform Product Portfolio Table 119. American Medical Software Recent Development Table 120. Clearwave Company Information Table 121. Clearwave Business Overview Table 122. Clearwave Patient Scheduling Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Clearwave Patient Scheduling Platform Product Portfolio Table 124. Clearwave Recent Development Table 125. Upvio Company Information Table 126. Upvio Business Overview Table 127. Upvio Patient Scheduling Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. Upvio Patient Scheduling Platform Product Portfolio Table 129. Upvio Recent Development Table 130. TIMIFY Company Information Table 131. TIMIFY Business Overview Table 132. TIMIFY Patient Scheduling Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. TIMIFY Patient Scheduling Platform Product Portfolio Table 134. TIMIFY Recent Development Table 135. Nuesoft Technologies Company Information Table 136. Nuesoft Technologies Business Overview Table 137. Nuesoft Technologies Patient Scheduling Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 138. Nuesoft Technologies Patient Scheduling Platform Product Portfolio Table 139. Nuesoft Technologies Recent Development Table 140. North America Patient Scheduling Platform Revenue by Type (2021-2026) & (US$ Million) Table 141. North America Patient Scheduling Platform Revenue by Type (2027-2032) & (US$ Million) Table 142. North America Patient Scheduling Platform Revenue by Application (2021-2026) & (US$ Million) Table 143. North America Patient Scheduling Platform Revenue by Application (2027-2032) & (US$ Million) Table 144. North America Patient Scheduling Platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. North America Patient Scheduling Platform Revenue by Country (2021-2026) & (US$ Million) Table 146. North America Patient Scheduling Platform Revenue by Country (US$ Million) & (2027-2032) Table 147. Europe Patient Scheduling Platform Revenue by Type (2021-2026) & (US$ Million) Table 148. Europe Patient Scheduling Platform Revenue by Type (2027-2032) & (US$ Million) Table 149. Europe Patient Scheduling Platform Revenue by Application (2021-2026) & (US$ Million) Table 150. Europe Patient Scheduling Platform Revenue by Application (2027-2032) & (US$ Million) Table 151. Europe Patient Scheduling Platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 152. Europe Patient Scheduling Platform Revenue by Country (2021-2026) & (US$ Million) Table 153. Europe Patient Scheduling Platform Revenue by Country (US$ Million) & (2027-2032) Table 154. China Patient Scheduling Platform Revenue by Type (2021-2026) & (US$ Million) Table 155. China Patient Scheduling Platform Revenue by Type (2027-2032) & (US$ Million) Table 156. China Patient Scheduling Platform Revenue by Application (2021-2026) & (US$ Million) Table 157. China Patient Scheduling Platform Revenue by Application (2027-2032) & (US$ Million) Table 158. Asia Patient Scheduling Platform Revenue by Type (2021-2026) & (US$ Million) Table 159. Asia Patient Scheduling Platform Revenue by Type (2027-2032) & (US$ Million) Table 160. Asia Patient Scheduling Platform Revenue by Application (2021-2026) & (US$ Million) Table 161. Asia Patient Scheduling Platform Revenue by Application (2027-2032) & (US$ Million) Table 162. Asia Patient Scheduling Platform Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 163. Asia Patient Scheduling Platform Revenue by Region (US$ Million) & (2021-2026) Table 164. Asia Patient Scheduling Platform Revenue by Region (US$ Million) & (2027-2032) Table 165. SAMEA Patient Scheduling Platform Revenue by Type (2021-2026) & (US$ Million) Table 166. SAMEA Patient Scheduling Platform Revenue by Type (2027-2032) & (US$ Million) Table 167. SAMEA Patient Scheduling Platform Revenue by Application (2021-2026) & (US$ Million) Table 168. SAMEA Patient Scheduling Platform Revenue by Application (2027-2032) & (US$ Million) Table 169. SAMEA Patient Scheduling Platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. SAMEA Patient Scheduling Platform Revenue by Country (2021-2026) & (US$ Million) Table 171. SAMEA Patient Scheduling Platform Revenue by Country (US$ Million) & (2027-2032) Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. Patient Scheduling Platform Image Figure 2. Global Patient Scheduling Platform Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Patient Scheduling Platform Market Size Share 2021 VS 2025 VS 2032 Figure 4. Cloud-based Image Figure 5. On-premise Image Figure 6. Global Patient Scheduling Platform Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Patient Scheduling Platform Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Specialist Clinic Image Figure 10. Others Image Figure 11. Global Patient Scheduling Platform Market Size (US$ Million) & (2021-2032) Figure 12. Global Patient Scheduling Platform Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Patient Scheduling Platform Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Patient Scheduling Platform Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Patient Scheduling Platform Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Patient Scheduling Platform Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Patient Scheduling Platform Revenue Market Share by Type (2021-2032) Figure 19. Global Patient Scheduling Platform Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Patient Scheduling Platform Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Patient Scheduling Platform Revenue Market Share by Application (2021-2032) Figure 22. North America Patient Scheduling Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Patient Scheduling Platform Revenue Share by Type (2021-2032) Figure 24. North America Patient Scheduling Platform Revenue Share by Application (2021-2032) Figure 25. North America Patient Scheduling Platform Revenue Share by Country (2021-2032) Figure 26. United States Patient Scheduling Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Patient Scheduling Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Patient Scheduling Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Patient Scheduling Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Patient Scheduling Platform Revenue Share by Type (2021-2032) Figure 31. Europe Patient Scheduling Platform Revenue Share by Application (2021-2032) Figure 32. Europe Patient Scheduling Platform Revenue Share by Country (2021-2032) Figure 33. Germany Patient Scheduling Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Patient Scheduling Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Patient Scheduling Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Patient Scheduling Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Patient Scheduling Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Patient Scheduling Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Patient Scheduling Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Patient Scheduling Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Patient Scheduling Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Patient Scheduling Platform Revenue Share by Type (2021-2032) Figure 43. China Patient Scheduling Platform Revenue Share by Application (2021-2032) Figure 44. Asia Patient Scheduling Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Patient Scheduling Platform Revenue Share by Type (2021-2032) Figure 46. Asia Patient Scheduling Platform Revenue Share by Application (2021-2032) Figure 47. Asia Patient Scheduling Platform Revenue Share by Region (2021-2032) Figure 48. Japan Patient Scheduling Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Patient Scheduling Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Patient Scheduling Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Patient Scheduling Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Patient Scheduling Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Patient Scheduling Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Patient Scheduling Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Patient Scheduling Platform Revenue Share by Type (2021-2032) Figure 56. SAMEA Patient Scheduling Platform Revenue Share by Application (2021-2032) Figure 57. SAMEA Patient Scheduling Platform Revenue Share by Country (2021-2032) Figure 58. Brazil Patient Scheduling Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Patient Scheduling Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Patient Scheduling Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Patient Scheduling Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Patient Scheduling Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Patient Scheduling Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Patient Scheduling Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Patient Scheduling Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Patient Scheduling Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Patient Scheduling Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Patient Scheduling Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud-based
  • On-premise
Applications
  • Hospital
  • Specialist Clinic
  • Others
Companies covered
  • WellSky Scheduling
  • AdvancedMD
  • Weave
  • Carepatron
  • DoctorConnect.net
  • McKesson
  • WebPT
  • Yocale
  • Luma Health
  • Setmore
  • oicent Communications
  • Total Recall Solutions
  • Mediware Information Systems
  • TimeTrade Systems
  • Relatient
  • Skedulo
  • American Medical Software
  • Clearwave
  • Upvio
  • TIMIFY
  • Nuesoft Technologies

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Patient Scheduling Platform Market by Type
  3. 1.2.1 Global Patient Scheduling Platform Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Cloud-based
  5. 1.2.3 On-premise
  6. 1.3 Patient Scheduling Platform Market by Application
  7. 1.3.1 Global Patient Scheduling Platform Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Specialist Clinic
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Patient Scheduling Platform Market Dynamics
  1. 2.1 Patient Scheduling Platform Industry Trends
  2. 2.2 Patient Scheduling Platform Industry Drivers
  3. 2.3 Patient Scheduling Platform Industry Opportunities and Challenges
  4. 2.4 Patient Scheduling Platform Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Patient Scheduling Platform Market Perspective (2021-2032)
  2. 3.2 Global Patient Scheduling Platform Growth Trends by Region
  3. 3.2.1 Global Patient Scheduling Platform Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Patient Scheduling Platform Market Size by Region (2021-2026)
  5. 3.2.3 Global Patient Scheduling Platform Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Patient Scheduling Platform Revenue by Players
  2. 4.1.1 Global Patient Scheduling Platform Revenue by Players (2021-2026)
  3. 4.1.2 Global Patient Scheduling Platform Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Patient Scheduling Platform Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Patient Scheduling Platform Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Patient Scheduling Platform Key Players Headquarters & Area Served
  7. 4.4 Global Patient Scheduling Platform Players, Product Type & Application
  8. 4.5 Global Patient Scheduling Platform Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Patient Scheduling Platform Market CR5 and HHI
  11. 4.6.3 2025 Patient Scheduling Platform Tier 1, Tier 2, and Tier 3
5 Patient Scheduling Platform Market Size by Type
  1. 5.1 Global Patient Scheduling Platform Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Patient Scheduling Platform Revenue by Type (2021-2032)
  3. 5.3 Global Patient Scheduling Platform Revenue Market Share by Type (2021-2032)
6 Patient Scheduling Platform Market Size by Application
  1. 6.1 Global Patient Scheduling Platform Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Patient Scheduling Platform Revenue by Application (2021-2032)
  3. 6.3 Global Patient Scheduling Platform Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 WellSky Scheduling
  2. 7.1.1 WellSky Scheduling Company Information
  3. 7.1.2 WellSky Scheduling Business Overview
  4. 7.1.3 WellSky Scheduling Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
  5. 7.1.4 WellSky Scheduling Patient Scheduling Platform Product Portfolio
  6. 7.1.5 WellSky Scheduling Recent Developments
  7. 7.2 AdvancedMD
  8. 7.2.1 AdvancedMD Company Information
  9. 7.2.2 AdvancedMD Business Overview
  10. 7.2.3 AdvancedMD Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
  11. 7.2.4 AdvancedMD Patient Scheduling Platform Product Portfolio
  12. 7.2.5 AdvancedMD Recent Developments
  13. 7.3 Weave
  14. 7.3.1 Weave Company Information
  15. 7.3.2 Weave Business Overview
  16. 7.3.3 Weave Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Weave Patient Scheduling Platform Product Portfolio
  18. 7.3.5 Weave Recent Developments
  19. 7.4 Carepatron
  20. 7.4.1 Carepatron Company Information
  21. 7.4.2 Carepatron Business Overview
  22. 7.4.3 Carepatron Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Carepatron Patient Scheduling Platform Product Portfolio
  24. 7.4.5 Carepatron Recent Developments
  25. 7.5 DoctorConnect.net
  26. 7.5.1 DoctorConnect.net Company Information
  27. 7.5.2 DoctorConnect.net Business Overview
  28. 7.5.3 DoctorConnect.net Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
  29. 7.5.4 DoctorConnect.net Patient Scheduling Platform Product Portfolio
  30. 7.5.5 DoctorConnect.net Recent Developments
  31. 7.6 McKesson
  32. 7.6.1 McKesson Company Information
  33. 7.6.2 McKesson Business Overview
  34. 7.6.3 McKesson Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
  35. 7.6.4 McKesson Patient Scheduling Platform Product Portfolio
  36. 7.6.5 McKesson Recent Developments
  37. 7.7 WebPT
  38. 7.7.1 WebPT Company Information
  39. 7.7.2 WebPT Business Overview
  40. 7.7.3 WebPT Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
  41. 7.7.4 WebPT Patient Scheduling Platform Product Portfolio
  42. 7.7.5 WebPT Recent Developments
  43. 7.8 Yocale
  44. 7.8.1 Yocale Company Information
  45. 7.8.2 Yocale Business Overview
  46. 7.8.3 Yocale Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Yocale Patient Scheduling Platform Product Portfolio
  48. 7.8.5 Yocale Recent Developments
  49. 7.9 Luma Health
  50. 7.9.1 Luma Health Company Information
  51. 7.9.2 Luma Health Business Overview
  52. 7.9.3 Luma Health Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Luma Health Patient Scheduling Platform Product Portfolio
  54. 7.9.5 Luma Health Recent Developments
  55. 7.10 Setmore
  56. 7.10.1 Setmore Company Information
  57. 7.10.2 Setmore Business Overview
  58. 7.10.3 Setmore Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Setmore Patient Scheduling Platform Product Portfolio
  60. 7.10.5 Setmore Recent Developments
  61. 7.11 oicent Communications
  62. 7.11.1 oicent Communications Company Information
  63. 7.11.2 oicent Communications Business Overview
  64. 7.11.3 oicent Communications Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
  65. 7.11.4 oicent Communications Patient Scheduling Platform Product Portfolio
  66. 7.11.5 oicent Communications Recent Developments
  67. 7.12 Total Recall Solutions
  68. 7.12.1 Total Recall Solutions Company Information
  69. 7.12.2 Total Recall Solutions Business Overview
  70. 7.12.3 Total Recall Solutions Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Total Recall Solutions Patient Scheduling Platform Product Portfolio
  72. 7.12.5 Total Recall Solutions Recent Developments
  73. 7.13 Mediware Information Systems
  74. 7.13.1 Mediware Information Systems Company Information
  75. 7.13.2 Mediware Information Systems Business Overview
  76. 7.13.3 Mediware Information Systems Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Mediware Information Systems Patient Scheduling Platform Product Portfolio
  78. 7.13.5 Mediware Information Systems Recent Developments
  79. 7.14 TimeTrade Systems
  80. 7.14.1 TimeTrade Systems Company Information
  81. 7.14.2 TimeTrade Systems Business Overview
  82. 7.14.3 TimeTrade Systems Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
  83. 7.14.4 TimeTrade Systems Patient Scheduling Platform Product Portfolio
  84. 7.14.5 TimeTrade Systems Recent Developments
  85. 7.15 Relatient
  86. 7.15.1 Relatient Company Information
  87. 7.15.2 Relatient Business Overview
  88. 7.15.3 Relatient Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Relatient Patient Scheduling Platform Product Portfolio
  90. 7.15.5 Relatient Recent Developments
  91. 7.16 Skedulo
  92. 7.16.1 Skedulo Company Information
  93. 7.16.2 Skedulo Business Overview
  94. 7.16.3 Skedulo Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Skedulo Patient Scheduling Platform Product Portfolio
  96. 7.16.5 Skedulo Recent Developments
  97. 7.17 American Medical Software
  98. 7.17.1 American Medical Software Company Information
  99. 7.17.2 American Medical Software Business Overview
  100. 7.17.3 American Medical Software Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
  101. 7.17.4 American Medical Software Patient Scheduling Platform Product Portfolio
  102. 7.17.5 American Medical Software Recent Developments
  103. 7.18 Clearwave
  104. 7.18.1 Clearwave Company Information
  105. 7.18.2 Clearwave Business Overview
  106. 7.18.3 Clearwave Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Clearwave Patient Scheduling Platform Product Portfolio
  108. 7.18.5 Clearwave Recent Developments
  109. 7.19 Upvio
  110. 7.19.1 Upvio Company Information
  111. 7.19.2 Upvio Business Overview
  112. 7.19.3 Upvio Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Upvio Patient Scheduling Platform Product Portfolio
  114. 7.19.5 Upvio Recent Developments
  115. 7.20 TIMIFY
  116. 7.20.1 TIMIFY Company Information
  117. 7.20.2 TIMIFY Business Overview
  118. 7.20.3 TIMIFY Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
  119. 7.20.4 TIMIFY Patient Scheduling Platform Product Portfolio
  120. 7.20.5 TIMIFY Recent Developments
  121. 7.21 Nuesoft Technologies
  122. 7.21.1 Nuesoft Technologies Company Information
  123. 7.21.2 Nuesoft Technologies Business Overview
  124. 7.21.3 Nuesoft Technologies Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
  125. 7.21.4 Nuesoft Technologies Patient Scheduling Platform Product Portfolio
  126. 7.21.5 Nuesoft Technologies Recent Developments
8 North America
  1. 8.1 North America Patient Scheduling Platform Revenue (2021-2032)
  2. 8.2 North America Patient Scheduling Platform Revenue by Type (2021-2032)
  3. 8.2.1 North America Patient Scheduling Platform Revenue by Type (2021-2026)
  4. 8.2.2 North America Patient Scheduling Platform Revenue by Type (2027-2032)
  5. 8.3 North America Patient Scheduling Platform Revenue Share by Type (2021-2032)
  6. 8.4 North America Patient Scheduling Platform Revenue by Application (2021-2032)
  7. 8.4.1 North America Patient Scheduling Platform Revenue by Application (2021-2026)
  8. 8.4.2 North America Patient Scheduling Platform Revenue by Application (2027-2032)
  9. 8.5 North America Patient Scheduling Platform Revenue Share by Application (2021-2032)
  10. 8.6 North America Patient Scheduling Platform Revenue by Country
  11. 8.6.1 North America Patient Scheduling Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Patient Scheduling Platform Revenue by Country (2021-2026)
  13. 8.6.3 North America Patient Scheduling Platform Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Patient Scheduling Platform Revenue (2021-2032)
  2. 9.2 Europe Patient Scheduling Platform Revenue by Type (2021-2032)
  3. 9.2.1 Europe Patient Scheduling Platform Revenue by Type (2021-2026)
  4. 9.2.2 Europe Patient Scheduling Platform Revenue by Type (2027-2032)
  5. 9.3 Europe Patient Scheduling Platform Revenue Share by Type (2021-2032)
  6. 9.4 Europe Patient Scheduling Platform Revenue by Application (2021-2032)
  7. 9.4.1 Europe Patient Scheduling Platform Revenue by Application (2021-2026)
  8. 9.4.2 Europe Patient Scheduling Platform Revenue by Application (2027-2032)
  9. 9.5 Europe Patient Scheduling Platform Revenue Share by Application (2021-2032)
  10. 9.6 Europe Patient Scheduling Platform Revenue by Country
  11. 9.6.1 Europe Patient Scheduling Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Patient Scheduling Platform Revenue by Country (2021-2026)
  13. 9.6.3 Europe Patient Scheduling Platform Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Patient Scheduling Platform Revenue (2021-2032)
  2. 10.2 China Patient Scheduling Platform Revenue by Type (2021-2032)
  3. 10.2.1 China Patient Scheduling Platform Revenue by Type (2021-2026)
  4. 10.2.2 China Patient Scheduling Platform Revenue by Type (2027-2032)
  5. 10.3 China Patient Scheduling Platform Revenue Share by Type (2021-2032)
  6. 10.4 China Patient Scheduling Platform Revenue by Application (2021-2032)
  7. 10.4.1 China Patient Scheduling Platform Revenue by Application (2021-2026)
  8. 10.4.2 China Patient Scheduling Platform Revenue by Application (2027-2032)
  9. 10.5 China Patient Scheduling Platform Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Patient Scheduling Platform Revenue (2021-2032)
  2. 11.2 Asia Patient Scheduling Platform Revenue by Type (2021-2032)
  3. 11.2.1 Asia Patient Scheduling Platform Revenue by Type (2021-2026)
  4. 11.2.2 Asia Patient Scheduling Platform Revenue by Type (2027-2032)
  5. 11.3 Asia Patient Scheduling Platform Revenue Share by Type (2021-2032)
  6. 11.4 Asia Patient Scheduling Platform Revenue by Application (2021-2032)
  7. 11.4.1 Asia Patient Scheduling Platform Revenue by Application (2021-2026)
  8. 11.4.2 Asia Patient Scheduling Platform Revenue by Application (2027-2032)
  9. 11.5 Asia Patient Scheduling Platform Revenue Share by Application (2021-2032)
  10. 11.6 Asia Patient Scheduling Platform Revenue by Country
  11. 11.6.1 Asia Patient Scheduling Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Patient Scheduling Platform Revenue by Country (2021-2026)
  13. 11.6.3 Asia Patient Scheduling Platform Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Patient Scheduling Platform Revenue (2021-2032)
  2. 12.2 SAMEA Patient Scheduling Platform Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Patient Scheduling Platform Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Patient Scheduling Platform Revenue by Type (2027-2032)
  5. 12.3 SAMEA Patient Scheduling Platform Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Patient Scheduling Platform Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Patient Scheduling Platform Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Patient Scheduling Platform Revenue by Application (2027-2032)
  9. 12.5 SAMEA Patient Scheduling Platform Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Patient Scheduling Platform Revenue by Country
  11. 12.6.1 SAMEA Patient Scheduling Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Patient Scheduling Platform Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Patient Scheduling Platform Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research